An evaluation of the adequacy of outpatient monitoring of thyroid replacement therapy

Journal of Evaluation in Clinical Practice

Volumn 10, Issue 4, 2004, Pages 525-530

  Stelfox, Henry Thomas ^a,b,c   Ahmed, Sofia B ^c   Fiskio, Julie ^d   Bates, David W ^c,d  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Partners Information Systems   (United States)

Author keywords

Adverse drug events; Levothyroxine; Medication safety; Monitoring; Thyroid

Indexed keywords

LEVOTHYROXINE;

ADULT; AGED; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; DRUG INDUCED DISEASE; DRUG MONITORING; ERROR; ETHNOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; RADIATION; REVIEW; THYROID DISEASE; UNSTABLE ANGINA PECTORIS;

AMBULATORY CARE; DRUG MONITORING; HUMANS; HYPOTHYROIDISM; RETROSPECTIVE STUDIES; THYROXINE;

EID: 7944236530     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2003.00461.x     Document Type: Review

References (18)

1. AACE Thyroid Task Force (1995) Clinical Guidelines for the Evaluation and Treatment of Hyperthyroidism and Hypothyroidism. American Association of Clinical Endocrinologists, Jacksonville, FL.
2. Abookire S.A., Karson A.S., Fiskio J. & Bates D.W. (2001) Use and monitoring of 'statin' lipid-lowering drugs compared with guidelines. Archives of Internal Medicine 161, 53-58.
3. Bates D.W., Cullen D.J., Laird N. et al. (1995) Incidence of adverse drug events and potential adverse drug events: implications for prevention. Journal of the American Medical Association 274, 29-34.
4. Braverman L.E. & Utiger R.D., eds. (2000) Werner and Ingbar's the Thyroid: a Fundamental and Clinical Text, 8th edn. Lippincott Williams & Wilkins, Philadelphia.
5. Canaris G., Manowitz N., Mayor G. & Ridgway C. (2000) The Colorado thyroid disease prevalence study. Archives of Internal Medicine 160, 526-534.
6. Canas F., Tanasijevic M., Ma'luf N. & Bates D. (1999) Evaluating the appropriateness of digoxin level monitoring. Archives of Internal Medicine 159, 363-368.
7. Charlson M.E., Pompei P., Ales K.L. & MacKenzie C.R. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Disease 40, 373-383.
8. Hougardy D., Peterson G., Bleasel M. & Randall C. (2000) Is enough attention being given to the adverse effects of corticosteroid therapy? Journal of Clinical Pharmacy and Therapeutics 25, 227-234.
9. Klein I. & Ojamaa K. (2001) Thyroid hormone and the cardiovascular system. New England Journal of Medicine 344, 501-509.
10. Kuperman G., Boyle D., Jha A et al. (1998) How promptly are inpatients treated for critical laboratory results? Journal the of American Medical Informatics Association 5, 112-119.
11. Landis J.R. & Koch G.G. (1977) The measurement of observer agreement for categorical data. Biometrics 331, 59-174.
12. Leape L.L., Brennan T.A., Laird N. et al. (1991) The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. New England Journal of Medicine 324, 377-384.
13. McDonald C.J. & Overhage J.M. (1994) Guidelines you can follow and trust. an ideal and an example. Journal of the American Medical Association 271, 872-873.
14. Ross D.S., Daniels G.H. & Gouveia D. (1990) The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an outpatient endocrine clinic. Journal of Clinical Endocrinological Metabolism 71, 764-769.
15. Schiff G., Hegde H., LaCloche L. & Hryhorczuk D. (1991) Inpatient theophylline toxicity: preventable factors. Annals of Internal Medicine 114, 748-753.
16. Schoenenberger R., Tanasijevic M., Jha A. & Bates D. (1995) Appropriateness of antiepileptic drug level monitoring. Journal of the American Medical Association 274, 1622-1626.
17. Singer P., Cooper D., Levy E. et al. (1995) Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Journal of the American Medical Association 273, 808-812.
18. Vanderpump M., Ahlquist J., Franklyn J. & Clayton R. (1996) Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. British Medical Journal 313, 539-544.